PATENT CLAIM ANALYSIS

Application Number: 15988947
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["536", "024500"]

Abstract:
The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.

Claim (Index 20):
The pharmaceutically acceptable nanoparticle of  claim 1 , wherein the nucleic acid is substantially stable in a Dnase assay.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.18519
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14656899', '15860881', '13910328', '15118737', '14091343']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6478035820301876
- 35 USC 102 Novelty (BERT): 0.50979594656479
- Combined Prediction Score: 0.6340028184836479
- Mean Citation Score: 272.850088
- Max Citation Score: 282.66974
- Similarity Product: 186.80574834517955

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test